NEWS & ARTICLES

HOME // BLOG POST DETAILS
Safety and Immunogenicity Profile of Human Papillomavirus-16/18 AS04 Adjuvant Cervical Cancer Vaccine: A Randomized Controlled Trial in Healthy Adolescent Girls of Bangladesh

Safety and Immunogenicity Profile of Human Papillomavirus-16/18 AS04 Adjuvant Cervical Cancer Vaccine: A Randomized Controlled Trial in Healthy Adolescent Girls of Bangladesh

GOSB

Email Me

COMMENT (0)

Copyright © 2025 GOSB. All Rights Reserved.
Design & Developed By in collaboration with Incepta.